Dr. Cush reviews the news, and kicks off ACR21 learning and how to take in the annual meeting.
All News
Article
Article
Mysteries behind polyautoimmunity have confounded rheumatologists for decades. One such association, the co-existence of Familial Mediterranean Fever (FMF) and axial spondyloarthritis (axSpA), remains rare. In fact, we believe the rate to be between 0.5% and 7.5%.
Article
Since the start of the pandemic, hydroxychloroquine (HCQ) was forced into the limelight for the prevention/treatment of COVID-19.
Bella Mehta
Tweet
How to improve clinical care for knee OA? stepped exercise program helps WOMAC self reported pain outcomes in Knee OA Important RCT #ACR21 year in review by @karen_kc123 @RheumNow
@AnnalsofIM here is a paper https://t.co/RGIjBL9TuZ
Cassandra Calabrese
Tweet
Join us tomorrow at #ACR21 in the #COVID19 hub at 12p EST where I’ll be discussing outpatient management of high risk covid patients with @LCalabreseDO #mAbs @philipcrobinson @ACRheum https://t.co/LkSw48cnWw
Dr.Hala Fadhil , MD
Tweet
All respect to Dr.Alarcon
As she presents her path to rheumatology practice #ACR21 #rheumatology #RheumTwitter https://t.co/JKaeUEvqkx
LiSa ◡̈︎
Tweet
#ACR21 Anti-IFN autoantibodies predisposing patients to severe COVID ...🤔 And can be done with quantiferon test! https://t.co/n3h4vpQGdR
Meral K. El Ramahi, MD
Tweet
@DoctorYasmin concludes her wonderful, innovative keynote address by noting 2 things she would like to see change moving forward:
1. How we tend to the wellness of providers
2. Improving communication amongst medical colleagues & communication to the public.
#ACR21 @RheumNow https://t.co/BdyVgVr0on
Bella Mehta
Tweet
There is a lot of talk about #COVID19 vaccines, however we don't much about existing vaccines (eg flu) in our patients! Much more work to be done here in rheumatology! @DrDavidKarp at #ACR21 opening session @rheumnow
Eric Dein
Tweet
@DoctorYasmin: "Let's talk about the history ... let's build bridges." We individualize approach to treatments, we should also individualize our conversation about vaccine hesitancy to your patient's specific concerns. @rheumnow #ACR21 https://t.co/1Jxw8l2phB
David Liew
Tweet
@DoctorYasmin @RheumNow Great discussion #ACR21 @DoctorYasmin: how do we stop panic/misinformation during a pandemic?
To improve health literacy, we need to learn how to engage better:
- understand the issues/public thinking
- targeted messaging to different communities
- avoid medical hubris
@RheumNow https://t.co/FLvPvX3UJc
Eric Dein
Tweet
@DrDavidKarp: "We are learning about #COVID19 vaccine, but we don't know what to do about the other vaccines." Its a great opportunity for us to learn, research, and educate about the flu, shingles, pneumonia, and more vaccines. 💉 @RheumNow #ACR21
"I am often asked when are we going back to normal? NO! I don't want to go back to Normal....we need systems that are more resilient" @DoctorYasmin on lessons learned from #COVID to prepare for future challenges/outbreaks #ACR21 @RheumNow https://t.co/DAdCH80uQ5
Meral K. El Ramahi, MD
Tweet
@DoctorYasmin notes that anti-vaccination is not a new phenomenon & that we cannot adopt a "one size fits all" method in tackling vaccine hesitancy. She emphasizes the need for targeted messaging & the ideology that vaccination is anti-American must be debunked! #ACR21 @RheumNow https://t.co/cU33XEOYhM
David Liew
Tweet
"If we go back to business as usual, we will have failed." @DoctorYasmin in the #ACR21 Opening Session.
We need systems that don't need a crisis to shine on them to progressively change for the better. @RheumNow https://t.co/uf4OO2VpHV
Meral K. El Ramahi, MD
Tweet
So excited to cover the annual #ACR21 Convergence Conference aside the amazing @Rheumnow Faculty team. A hearty congratulations to our wonderful leader, Dr. Jack Cush @RheumNowNews, for the well-earned designation as an ACR Master. https://t.co/v6fAyqH1CU
David Liew
Tweet
Congratulations to all the ACR Masters announced in the #ACR21 Opening Session, particularly @RheumNow's Jack Cush.
It's been such a privilege learning from you. Amongst all you've done, thank you for opening up the global rheumatology discussion like never before. True impact! https://t.co/MMh8owLfY6


